Skip to main content
. 2022 Jul 20;6(7):e22.00141. doi: 10.5435/JAAOSGlobal-D-22-00141

Table 4.

Factors Associated With Total Volume of Intraoperative Blood Loss

Total volume of intraoperative blood loss Unadjusted P value Adjusted P valuea
Implant type, median (IQR) 0.052 0.005
 Stemless aTSA 298.3 (212.6-402.8)
 Short-stem aTSA 359.7 (253.9-415.0)
Age, Spearman correlation r = −0.060 0.503 b
Sex, median (IQR) 0.031 0.001
 Female 299.7 (212.6-383.2)
 Male 357.2 (257.9-455.6)
BMI (Spearman correlation) r = 0.089 0.312 0.041
ASA, median (IQR) 0.806 b
 1-2 326.3 (229.2-412.1)
 ≥3 323.0 (235.1-406.7)
ACCI (Spearman correlation) r = 0.022 0.803 b
Prior ipsilateral arthroscopy (median (IQR)) 0.631 b
 No 318.7 (218.1-412.1)
 Yes 346.2 (266.0-402.2)
Hemovac use, median (IQR) 0.074 b
 No 274.8 (182.9-400.4)
 Yes 337.1 (237.8-412.1)
Transexamic acid use, median (IQR) 0.704 b
 No 299.6 (280.7-400.4)
 Yes 326.3 (225.5-412.0)
Anesthesia, median (IQR) 0.441 b
 General alone 246.9 (151.5-412.1)
 General/regional 326.3 (232.7-409.7)
Use of augmented polyethylene, median (IQR) 0.344 b
 No 312.9 (232.7-404.9)
 Yes 349.7 (221.8-460.6)
Surgical side, median (IQR) 0.482 b
 Right 318.1 (239.5-419.4)
 Left 325.4 (191.4-405.2)

ACCI = age-adjusted Charlson Comorbidity Index, ASA = American Society of Anesthesiologists, IQR = interquartile range

a

Adjusted P values were obtained from nonparametric analysis of covariance. This analysis was based on the ranks of total volume of intraoperative blood loss.

b

Variables did not remain in the nonparametric analysis of covariance model at a 0.05 significance level.